SEMINAR: Trends in Clinical Trials Workshop: Informed Consent 6/6/2017

Event Address: 

Gleacher Center
450 N Cityfront Plaza Dr
Chicago, IL 60611

Online Registration only.

Open to anyone


Informed consent is one of the most important parts in conducting human subjects research. This workshop will provide a thought provoking look at the history of informed consent and the critical elements that need to be included in the actual informed consent document. The goal of this workshop will guide participants in the following:

  • Understand the basis and importance of informed consent
  • Provide guidance on how to write a consent document that is easily understood by the lay study participant
  • How to execute the informed consent process so that it is truly informative

Hosted By: Lauren Wall and Amanda Spratt

Lauren Wall - Director, Clinical Research Operations University of Chicago - Department of Medicine, Section of Hematology Oncology

Lauren has over 11 years of experience in Hematology/Oncology clinical research operations spanning industry and academic healthcare. Lauren currently oversees the clinical research operations in the section of Hematology Oncology at the University of Chicago. Her primary responsibilities include planning, organizing, directing, and overseeing daily clinical research for over 300+ clinical trials. Prior to taking her role in the academic setting, Lauren worked at an Oncology CRO where she gained experience in clinical trial monitoring, auditing and project management. Lauren holds an MSc degree in Clinical Research Administration from the George Washington University.

Amanda Spratt – Technical Director of the Cancer Center Regulatory and Compliance Office

Amanda recently assumed the position of Technical Director of the Cancer Center Regulatory and Compliance Office. Amanda received her BS in Biology from Boston College and has more than 12 years of experience in regulatory affairs and clinical cancer research.  She has a detailed understanding of the framework of clinical cancer research, including protocol design, biomarker strategies, FDA submissions (IND/IDE), consent form development, and regulatory requirements of both clinical sites and commercial sponsors.

Course Code: 



June 6, 2017
6:00 PM–7:30 PM CST


Unlimited slots available